Exact Sciences (EXAS)
(Real Time Quote from BATS)
$55.02 USD
-4.46 (-7.50%)
Updated May 9, 2024 01:27 PM ET
3-Hold of 5 3
D Value B Growth B Momentum B VGM
Price, Consensus and EPS Surprise
EXAS 55.02 -4.46(-7.50%)
Will EXAS be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for EXAS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EXAS
Exact Sciences (EXAS) Q1 Revenues Rise Y/Y, Gross Margin Down
Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates
EXAS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates
Should Invesco FTSE RAFI US 1500 Small-Mid ETF (PRFZ) Be on Your Investing Radar?
Techne (TECH) Q3 Earnings and Revenues Beat Estimates
Other News for EXAS
Stocks Rebound As Rising Jobless Claims Sustain Rate-Cut Hopes, Dollar Falls, Gold Rallies: What's Driving Markets Thursday?
Analysts’ Top Healthcare Picks: US Physical Therapy (USPH), Exact Sciences (EXAS)
Buy Rating Reiterated for Exact Sciences on Strong Q1 Performance and Positive Financial Outlook
Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Thursday's Pre-Market Session